Comparative Analysis of Serum Proteomes of Moyamoya Disease and Normal Controls.
Eun Jeong Koh, Han Na Kim, Tian Ze Ma, Ha Young Choi, Yong Geun Kwak
J Korean Neurosurg Soc. 2010;48(1):8-13.     DOI: https://doi.org/10.3340/jkns.2010.48.1.8
Citations to this article as recorded by Crossref logo
Upregulated Cytoskeletal Proteins Promote Pathological Angiogenesis in Moyamoya Disease
Shihao He, Junze Zhang, Ziqi Liu, Yanru Wang, Xiaokuan Hao, Xilong Wang, Zhenyu Zhou, Xun Ye, Yahui Zhao, Yuanli Zhao, Rong Wang
Stroke.2023; 54(12): 3153.     CrossRef
Genetic and Proteomic Contributions to the Pathophysiology of Moyamoya Angiopathy and Related Vascular Diseases
Kirsten B Dorschel, John E Wanebo
The Application of Clinical Genetics.2021; Volume 14: 145.     CrossRef
iTRAQ-based Quantitative Proteomic Analysis of Dural Tissues Reveals Upregulated Haptoglobin to be a Potential Biomarker of Moyamoya Disease
Xiaojun Zhang, Lin Yin, Xiaofang Jia, Yujiao Zhang, Tiefu Liu, Lijun Zhang
Current Proteomics.2021; 18(1): 27.     CrossRef
RATIONALIZATION OF SURGICAL TREATMENT FOR HEMORRHAGIC MOYAMOYA DISEASE: FROM LABORATORY BENCH RESEARCH, BIOMECHANICS TO META-ANALYSIS
ZHI-QUN JIANG, YAN CHEN, CHUN-HUI ZENG, JIU-GENG FENG, YI-LV WAN, MIN-JUN WEI
Journal of Mechanics in Medicine and Biology.2019; 19(05): 1950035.     CrossRef
Downregulation of Apolipoprotein-E and Apolipoprotein-J in Moyamoya Disease—A Proteome Analysis of Cerebrospinal Fluid
Daina Kashiwazaki, Haruto Uchino, Satoshi Kuroda
Journal of Stroke and Cerebrovascular Diseases.2017; 26(12): 2981.     CrossRef
Recent Advances in Moyamoya Disease: Pathophysiology and Treatment
Annick Kronenburg, Kees P. J. Braun, Albert van der Zwan, Catharina J. M. Klijn
Current Neurology and Neuroscience Reports.2014;[Epub]     CrossRef